2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, R Collins, M Antz, P Cornu, L Desteghe… - Ep …, 2021 - academic.oup.com
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

International consensus statement on allergy and rhinology: rhinosinusitis 2021

RR Orlandi, TT Kingdom, TL Smith… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …

COVID-19 and gastrointestinal disease: implications for the gastroenterologist

RH Hunt, JE East, A Lanas, P Malfertheiner… - Digestive …, 2021 - karger.com
Background: COVID-19 was initially considered a respiratory disease but the SARS-CoV-2
virus can lead to serious systemic consequences affecting major organs including the …

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

SL Mackie, C Dejaco, S Appenzeller… - …, 2020 - academic.oup.com
Background GCA is a large vessel vasculitis affecting older people, with the highest
incidence among persons 70–79 years of age [1]. Due to forecasted demographic changes …

Diagnosis and treatment of peptic ulcer disease

RT Kavitt, AM Lipowska, A Anyane-Yeboa… - The American journal of …, 2019 - Elsevier
Peptic ulcer disease continues to be a source of significant morbidity and mortality
worldwide. Approximately two-thirds of patients found to have peptic ulcer disease are …

Management of gastroesophageal reflux disease

CP Gyawali, R Fass - Gastroenterology, 2018 - Elsevier
Management of gastroesophageal reflux disease (GERD) commonly starts with an empiric
trial of proton pump inhibitor (PPI) therapy and complementary lifestyle measures, for …

Proton-pump inhibitors: understanding the complications and risks

P Malfertheiner, A Kandulski, M Venerito - … Reviews Gastroenterology & …, 2017 - nature.com
Proton-pump inhibitors (PPIs) are the most effective therapy for the full spectrum of gastric-
acid-related diseases. However, in the past decade, a steadily increasing list of …

[HTML][HTML] Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified

G Bruno, P Zaccari, G Rocco, G Scalese… - World journal of …, 2019 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) are common medications within the practice of
gastroenterology. These drugs, which act through the irreversible inhibition of the …

Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации

АЕ Каратеев, ЕЛ Насонов… - Научно …, 2018 - rsp.mediar-press.net
Аннотация В 2015 г. экспертами, представляющими различные врачебные ассоциации
России, были разработаны клинические рекомендации «Рациональное применение …